Commit To Buy GenMark Diagnostics At $7.50, Earn 8.1% Annualized Using Options
May 19, 2015 at 11:34 AM EDT
Investors considering a purchase of GenMark Diagnostics, Inc. (GNMK) shares, but cautious about paying the going market price of $9.38/share, might benefit from considering selling puts among the alternative strategies at their disposal..